Hypoxanthine: Early Biomarker in Neonatal Brain Injury
In a groundbreaking advancement in neonatal medicine, researchers have identified hypoxanthine as a critical early biomarker for predicting outcomes in neonatal hypoxic-ischemic encephalopathy (HIE) using...
















